The document discusses concepts, events, and biological processes involved in drug targeting. It defines drug targeting as selectively delivering pharmacologically active drugs to identified targets in therapeutic concentrations while restricting access to non-targets to minimize toxicity. It describes various strategies for drug targeting including chemical modifications, carrier-mediated delivery, and active targeting. It also outlines biological processes involved like cellular uptake, transport across epithelial barriers, extravasation into tissues, and lymphatic uptake that influence drug distribution. The presentation emphasizes how targeted delivery can improve efficacy and safety of drug therapy especially for cancer.

1. A Presentation on:
CONCEPTS,EVENTS AND
BIOLOGICAL PROCESSES
INVOLVED IN DRUG
TARGETTING Presented by-
SWASTIK JYOTI PAL
M.Pharm 2nd sem
Roll.no-01
Bengal School of Technology
Hooghly

2. WHY DRUG TARGETTING IS
NEEDED?
1.Pharmaceutical factors
• Drug instability in conventional dosage form
• Low Solubility
2.Biopharmaceutical factors
• Low absorption
• High-membrane bounding
• Biological instability
3.Pharmacokinetic / Pharmacodynamic
factors
• Short half-life
• Large volume of distribution
• Low specificity
4.Clinical factors
• Low therapeutic index.
5.Reaching difficult organs
* brain, retina, tumours
6.Intracellular drug delivery
* oligonucleotides,
intracellular proteins, genes
7.Prolonging drug response
* drug retention and release
are prolonged
(e.g. retina)

3. DRUG TARGETTING-concepts
Drug Targetting is selective and effective localization of the
pharmacologically-active moiety at preidentified target(s) in
therapeutic concentration, while restricting its access to non-
target(s) normal cellular linings, thus minimizing toxic effects and
maximizing the therapeutic index.
The drug may thus be delivered:
1. To the capillary bed of the active sites,
2. To the specific type of cell (or) even an intracellular region.
Ex- tumour cells but not to normal cells,
3. To a specific organ (or) tissues by complexing with the carrier
that recognizes the target

4.  The controlled and localized delivery of drugs and the
specific binding with the target receptors are specific
features of drug targeting.
 This leads to high drug concentration with higher
efficacy.
 The lower concentration at nontarget tissue lowers the
incidence of adverse effects and also decrease the dose.
 Chemotherapy of cancer is the most glaring example
where drug targeting is highly desirable.

5. PROPERTIES OF IDEAL TARGETTTED DRUG DELIVERY
SYSTEM-
1. Nontoxic, biocompatible and physicochemical stable in vivo and
invitro.
2. Restrict drug distribution to target cells or tissue or organ or
should have uniform capillary distribution.
3. Controllable and predictable rate of drug release.
4. Minimal drug leakage during transit.
5. Carrier used must be biodegradable or readily eliminated from
the body without any problem.
6. Its preparation should be easy or reasonably simple, reproductive
and cost effective.

6. TARGETED DRUG DELIVERY SYSTEM:
DRUG NANOCRYSTALS
LIPID BASED SYSTEMS
* micelles
* liposomes
* hexosomesand cubosomes
* solid lipid nanoparticles, nanoemulsions
* lipid complexes
POLYMER BASED SYSTEMS
* polymeric nanoparticles
* polymeric micelles
* polymeric conjugates
* dendrimers
* polymersomes
* polymer complexes
INORGANIC MATERIALS
* silicon, silica
* metals
* carbon nanotubes
MICROVESICLES
ANTIBODIES

7. COMPONENTS OF DRUG TARGETTING:
• Specific organ or a cell or group
of cells,which in chronic or acute
condition needtreatment.
Target
• Special molecules or system
essentially required for effective
transportation of loaded drug up
to the pre selected sites
Carrier

8. Strategies of
drug
targeting
Chemical
modification
Prodrug
approach
Chemical
delivery
system
Carrier
mediated
Active
targeting
First order Second order Third order
Passive
targeting
Inverse
targeting
Physical
targeting
Dual
targeting

9. Biologicalprocess
involvedindrugtargeting
Cellular uptake
and processing
Transport across
epithelial barrier
Extravasation
Lymphatic
uptake

10.  Following administration low molar mass drugs can enter into or pass through various cells by
simple diffusion process.
 Targeted drug delivery usually have macro molecular assemblies hence cannot enter by such simple
process. Hence take up by a process called ENDOCYTOSIS
 Steps involved :
Internalization of the plasma membrane
Concomitant with engulfment of extracellular material
 Compared with phagocytosis pinocytosis is a universal phenomenon in all the cells pinocytosis
does not require any external stimulus
 Pinocytosis is divided into two types:
Fluid phases pinocytosis
Adsorptive pinocytosis
 Compared with phagocytosis fluid phase pinocytic capture of molecules is relatively slower being
directly proportional to the concentration and size dependant
CELLULAR UPTAKE AND PROCESSING-

11.  The oral buccal nasal vaginal and rectal cavities are internally lined with one or
more layers of epithelial cells
 Depending on the position and function in the body epithelial cells can be varied
forms
 Three layer physiology:
 Epithelial, Lamia propria ,Basal lamina
 Low molar mass drugs cross the above by passive difussion carrier mediated
systems and selective and non-selective endocytosis
 The polar materials diffuse through tight junctions of epithelial cells
 Passive transport is usually higher in damaged mucosa where as active
transportdepends on structural integrity of epithelial cells
 Positively charged particles showed increased uptake than negatively charged
counterparts.
 Absoption of drugs from buccal via transcellular and paracellular later being
dominant.
TRANSPORT ACROSS EPITHELIAL BARRIER-

12.  Many diseases result from the dysfunction of cells located outside the cardiovascular system thus for a
drug to exert its therapeutic effects it must exit from the central circulation this process of trans vascular
exchange is called Extravasation which is governed by blood capillary walls.
 Factors that control permeability of capillaries
• Structure of the capillary wall
• Pathological condition
• Rate of blood and lymph supply
• Physicochemical factors of drug
 The structure of the blood capillary varies in different organs tissues.It consists of a single layer of
endothelia cells joined together by intercellular juctions.
 The endothelium of brain is the strongest of all endothelia formed by continuous nonfenestrated
endothelial cells which show no pinocytic activity
 Soluble macromolecules permeate the endothelial barrier more readily than particulate macromolecules
the rate of movement of fluid across the endothelium appears to be directly related to the difference
between the hydrostatic and osmotic forces.
EXTRAVASATION-

13. Following extravasation drug molecules can either reabsorb into the blood stream
directly or enter into the lymphatic system and return with the lymph to the blood
circulation
Also drugs administered by subcutaneous intracellular transdermal peritoneal routes
can reach the systemic circulation by lymphatic system
Factors know to influence the clearance of drugs from interstitial sites
1. Route of administration
2. Size and surface characteristics of particles
3. Formulation medium
4. The composition and
5. pH of the interstitial fluid and
6. Disease within the interstitium
The direct delivery of drugs into lymphatics has been proposed as a potential
approach to kill malignant lymphoid cells located in lymph nodes.
LYMPHATIC UPTAKE-

14.  Targeted drug delivery essentially implies for selective and effective
localization of the pharmacologically-active moiety at preidentified
target(s) in therapeutic concentration,
 Various strategies such as active targeting, passive targeting etc. can
be applied to achieve efficient drug targeting.
 The targeted delivery is of great importance in cancer chemotherapy
which always demands for reduction in adverse effect.
CONCLUSION-

15. 1. Muller, R; Keck, C (2004). "Challenges and solutions for the delivery
of biotech drugs – a review of drug nanocrystal technology and lipid
nanoparticles". Journal of Biotechnology 113 (1–3): 151–170.
doi:10.1016/j.jbiotec.2004.06.007
2. Introduction to novel drug delivery systems(2nd edition)-N.K Jain
,Vallabh prakashan , New Delhi,Pg-16-34
3. https://www.slideshare.net/vishnudatta/targeted-drug-delivery-systems
4. http://www.authorstream.com/Presentation/atitpandey-1737739-
biological-process-events-drug-targeting/
5. https://courses.helsinki.fi/sites/default/files/course-
material/4523810/BJK%20nano%20241017.pdf
REFERENCES-

16. THANK YOU!